Cardiff Oncology, Inc. (CRDF)

NASDAQ: CRDF · Real-Time Price · USD

2.445

-0.005 (-0.20%)

Aug 14, 2025, 2:36 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Novel Therapies for Cancers	683.00K	Log In	Log In	Log In	Log In	Upgrade
Novel Therapies for Cancers Growth	39.96%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	683.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	39.96%	Log In	Log In	Log In	Log In	Upgrade